Therefore, given the widespread use of incretin agonists for obesity treatment and weight loss, it is important to recognize their effects in the gastrointestinal tract, which could constitute significant benefits in weight loss and cardiometabolic benefits, but can be associated with adverse effects that constitute a potential barrier to their use, particularly at higher doses
Noticeable fat loss typically accelerates once you move through the gradual titration schedule and reach the stabilised maintenance doses
Despite the claims, Pfizer maintains that Depo-Provera is safe and effective, citing FDA approval and arguing that the scientific evidence does not support a causal link between the drug and brain tumors
ColonBroom is taking a more targeted approach
A collaborative approach involving endocrinology, primary care, and when appropriate, nutrition and mental health support, provides optimal outcomes for patients managing both thyroid and metabolic conditions